ARQ Arq, Inc.
Miscellaneous Chemical Products · Nasdaq · SEC CIK 1515156 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.3%
TTM net income YoY-966.8%
TTM EPS YoY-972.7%
Revenue 3-yr CAGR10.2%
Net income 3-yr CAGR—
Margins
Gross margin32.1%
Operating margin-38.8%
Net margin-39.0%
FCF margin1.1%
EBITDA margin-28.7%
Returns
ROE-25.4%
ROA-19.3%
ROIC (approx.)-18.5%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets26.4%
Debt / equity0.16x
Current ratio1.20x
Interest coverage-17.76x
Cash quality & payout
Operating cash flow / net income-0.10x
Accruals ratio-21.2%
Payout ratio—
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $120.34M | $108.96M | $99.18M | $102.99M | $100.29M |
| Cost of revenue | $86.80M | $69.52M | $67.32M | — | — |
| Gross profit | $33.53M | $39.44M | $31.86M | — | — |
| R&D expense | $7.34M | $4.05M | $3.31M | $2.10M | $400,000 |
| SG&A expense | $22.55M | $28.70M | $34.07M | $8.14M | $7.06M |
| Operating income | -$52.96M | -$1.96M | -$13.34M | -$12.07M | $4.85M |
| Interest expense | $2.45M | $3.26M | $3.01M | $336,000 | $1.49M |
| Pretax income | -$52.60M | -$5.27M | -$12.10M | -$8.71M | $76.07M |
| Income tax | $12,000 | -$164,000 | $153,000 | $209,000 | $15.67M |
| Net income | -$52.61M | -$5.11M | -$12.25M | -$8.92M | $60.40M |
| EBITDA | -$41.21M | $6.63M | -$2.79M | -$5.65M | $12.79M |
| EPS (basic) | -1.27 | -0.14 | -0.42 | -0.48 | 3.31 |
| EPS (diluted) | -1.27 | -0.14 | -0.42 | -0.48 | 3.27 |
| Weighted avg. shares (diluted) | 41.52M | 36.05M | 29.10M | 18.45M | 18.46M |
| Balance sheet | |||||
| Cash & equivalents | $6.57M | $22.23M | $54.15M | $76.43M | $88.78M |
| Receivables | $14.98M | $14.88M | $16.19M | $13.86M | $12.62M |
| Inventory | $15.89M | $19.31M | $19.69M | $17.83M | $7.85M |
| Current assets | $43.85M | $52.36M | $86.46M | $105.66M | $108.37M |
| PP&E, net | $143.15M | $178.56M | $94.65M | $34.85M | $30.17M |
| Intangibles | $570,000 | $7.57M | $7.90M | $847,000 | $1.24M |
| Total assets | $230.97M | $284.37M | $235.50M | $181.16M | $185.44M |
| Current liabilities | $42.30M | $44.65M | $23.05M | $23.88M | $22.62M |
| Short-term debt | $20.01M | $15.45M | $2.65M | $1.13M | $1.01M |
| Long-term debt | $8.45M | $9.37M | $18.27M | $3.45M | $3.15M |
| Total debt | $28.46M | $24.82M | $20.93M | $4.58M | $4.16M |
| Total liabilities | $62.62M | $67.09M | $57.10M | $41.19M | $38.13M |
| Shareholders' equity | $168.36M | $218.61M | $178.40M | $139.98M | $147.30M |
| Net debt | $21.89M | $2.59M | -$33.23M | -$71.85M | -$84.62M |
| Shares outstanding | 42.73M | 42.02M | 33.17M | 19.17M | 18.84M |
| Cash flow statement | |||||
| Operating cash flow | -$2.73M | $10.48M | -$16.65M | -$6.06M | $26.00M |
| Capital expenditure | $8.58M | $85.17M | $27.52M | $8.91M | $6.20M |
| Free cash flow | -$11.31M | -$74.69M | -$44.17M | -$14.97M | $19.80M |
| Investing cash flow | -$8.16M | -$85.07M | -$28.54M | -$4.61M | $44.38M |
| Financing cash flow | $3.70M | $42.68M | $22.91M | -$1.68M | -$17.53M |
| Depreciation & amortization | $11.75M | $8.59M | $10.54M | $6.42M | $7.93M |
| Stock-based compensation | $3.36M | $2.71M | $2.65M | $1.98M | $1.93M |
| Dividends paid | — | — | $0 | $45,000 | $93,000 |
| Share buybacks | — | — | — | — | $0 |
Free plan shows the latest 5 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.